Positions

Overview

  • Dr. McCarty is a physician in Infectious Diseases at the University of Alabama at Birmingham and the Birmingham Veterans Affairs Medical Center (BVAMC). He also serves as co-director of antimicrobial stewardship at the BVAMC. Dr. McCarty's research interests include transplant infectious diseases, fungal infections, and antimicrobial stewardship.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2021 Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency 2021
    2020 Reply to Tascini et alClinical Infectious Diseases.  70:1523-1524. 2020
    2019 Impact of infectious disease consultation on clinical management and mortality in patients with candidemiaClinical Infectious Diseases.  68:1585-1587. 2019
    2019 Amphotericin B induction with voriconazole consolidation as salvage therapy for FKS-associated echinocandin resistance in Candida glabrata septic arthritis and osteomyelitisAntimicrobial Agents and Chemotherapy.  63. 2019
    2018 Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experienceInfection Control and Hospital Epidemiology.  39:1419-1424. 2018
    2018 Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: Analysis of trends and outcomesJournal of Antimicrobial Chemotherapy.  73:1677-1680. 2018
    2016 Invasive CandidiasisInfectious Disease Clinics of North America.  30:103-124. 2016
    2015 Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Medical Mycology.  53:440-446. 2015
    2015 Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a reviewJournal of Clinical Virology.  66:48-50. 2015
    2014 The Evolving Epidemiology of SporotrichosisCurrent Fungal Infection Reports.  8:255-261. 2014
    2011 DiscussionAnnals of Thoracic Surgery.  91:1700-1701. 2011

    Investigator On

  • Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2020 - 2025
  • The Natural History of Antifungal Failure in Invasive Candidiasis in the United States  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2020 - 2022
  • Private Grant  awarded by MAYNE PHARMA INC 2018 - 2022
  • Private Grant  awarded by GENMARK DIAGNOSTICS 2020 - 2022
  • Private Grant  awarded by Gilead Sciences ^ 2016 - 2022
  • Private Grant  awarded by CONTRAFECT CORPORATION 2019 - 2022
  • Private Grant  awarded by SCYNEXIS 2017 - 2021
  • Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) COVID 19 SUPPLEMENT  awarded by Emory University 2020 - 2021
  • A Phase 2/3 Open-label, Randomized, Sequential Dose Escalation Cohort Study of T2307 Versus Standard of Care in Treatment of Subjects with Candidemia due to Candida Auris and other Drug-resistant Candida Species: An Adaptive Design Study  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2020 - 2021
  • COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2020 - 2021
  • Private Grant  awarded by MERCK & COMPANY, INC. ^ 2019 - 2021
  • High VS. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients  awarded by VANDERBILT UNIVERSITY 2017 - 2021
  • Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematpoietic Stem Cell and Solid Organ Transplant Recipients  awarded by Northwestern University 2016 - 2021
  • Convalescent Plasma Randomized Clinical Trials for SARS-CoV-2 Prophylaxis and Early COVID-19 Treatment are Foundational for Subsequent Hyperimmune Globulin and Vaccines  awarded by Johns Hopkins University 2020 - 2021
  • Private Grant  awarded by HOOKIPA BIOTECH 2019 - 2021
  • Private Grant  awarded by SUMMIT OXFORD LIMITED 2018 - 2021
  • (CSSC-001) Convalescent Plasma to Stem Coronavirus: A Randomized Controlled Double Blinded Phase 2 Study Comparing the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. control( SARS-CoV-2 non-immune plasma) among Adults Exposed to COVID-19 and (CSSC-004) Convalescent Plasma to Stem Coronavirus: A Randomized Controlled Double Blinded Phase 2 Study Comparing the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 non-immune plasma)  awarded by Johns Hopkins University 2020
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW 2016 - 2020
  • Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)  awarded by Duke University 2014 - 2019
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2013 - 2019
  • Private Grant  awarded by SHIRE PHARMACEUTICALS DEVELOPMENT, INC. 2017 - 2019
  • Private Grant  awarded by CRESTOVO LLC. 2017 - 2019
  • Private Grant  awarded by MERCK & COMPANY, INC. ^ 2018 - 2019
  • Private Grant  awarded by CONTRAFECT CORPORATION 2018 - 2019
  • Private Grant  awarded by SHIRE HUMAN GENETIC THERAPIES 2017 - 2019
  • Private Grant  awarded by VICAL, INC. 2018 - 2019
  • Private Grant  awarded by SERES THERAPEUTICS INC. 2018 - 2019
  • Private Grant  awarded by SERES THERAPEUTICS INC. 2018 - 2019
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016 - 2018
  • Private Grant  awarded by T2 BIOSYSTEMS 2016 - 2018
  • Private Grant  awarded by IMMUNO-MYCOLOGICS, INC. 2015 - 2018
  • B Cell Subsets and Infectious Immunity to Cryptococcosis  awarded by ALBERT EINSTEIN COLLEGE OF MEDICINE 2012 - 2018
  • Private Grant  awarded by ACTELION CLINICAL RESEARCH, INC. 2014 - 2017
  • A Prospective Cohort Study of Cryptococcus  awarded by Johns Hopkins University 2014 - 2017
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2015 - 2017
  • Private Grant  awarded by SCYNEXIS 2014 - 2016
  • Private Grant  awarded by SERES THERAPEUTICS INC. 2015 - 2016
  • Private Grant  awarded by SERES THERAPEUTICS INC. 2015 - 2016
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2013 - 2015
  • Private Grant  awarded by CUBIST PHARMACEUTICALS 2014 - 2015
  • Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 2010
  • Bachelor of Science or Mathematics in Biology, University of Alabama at Birmingham 2005
  • UAB Hospital, Internship 2011
  • UAB Hospital, Residency 2013
  • UAB Hospital, Postdoctoral Fellowship 2015
  • Full Name

  • Todd McCarty